Resmed Defer Conversions Between Registers
Key points
- Resmed announced deferral of conversions between US and Australian registers
- Deferral to avoid inconsistent dividend entitlements
- Conversions will not be processed from November 11 to November 12, 2026
- ASX granted waivers to allow deferral
Full summary
Resmed Inc. announced on October 30, 2026, the deferral of conversions between its US Common Stock register and its CHESS Depositary Interests (CDIs) register. This deferral is due to the differing settlement and transfer procedures between the New York Stock Exchange (NYSE) and the Australian Securities Exchange (ASX). The company sought and was granted waivers from ASX Settlement Operating Rules 13.9.4 and 13.9.9 to avoid inconsistent or duplicate dividend entitlements. As a result, no conversions will be processed from November 11, 2026, through November 12, 2026.
Summary generated by a large language model. Please interpret with care.